Author:
Crawford Cameron L.,Dalecki Alex G.,Perez Mildred D.,Schaaf Kaitlyn,Wolschendorf Frank,Kutsch Olaf
Abstract
AbstractMulti-drug resistant Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), has become a worldwide, major health care problem. While initially restricted to clinical settings, drug resistant S. aureus is now one of the key causative agents of community-acquired infections. We have previously demonstrated that copper dependent inhibitors (CDIs), a class of antibiotics that are only active in the presence of copper ions, are effective bactericidal agents against MRSA. A second-generation CDI, APT-6K, exerted bactericidal activity at nanomolar concentrations. At sub-bactericidal concentrations, it effectively synergized with ampicillin to reverse drug resistance in multiple MRSA strains. APT-6K had a favorable therapeutic index when tested on eukaryotic cells (TI: > 30) and, unlike some previously reported CDIs, did not affect mitochondrial activity. These results further establish inhibitors that are activated by the binding of transition metal ions as a promising class of antibiotics, and for the first time, describe their ability to reverse existing drug resistance against clinically relevant antibiotics.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Aslam, B. et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 11, 1645–1658, https://doi.org/10.2147/IDR.S173867 (2018).
2. Furuya, E. Y. & Lowy, F. D. Antimicrobial-resistant bacteria in the community setting. Nature reviews. Microbiology 4, 36–45, https://doi.org/10.1038/nrmicro1325 (2006).
3. O’Neill, J. UK review on antimicrobial resistance: tackling a crisis for the health and wealth of nations. https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf (2014).
4. Foster, T. J. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiology Reviews 41, 430–449, https://doi.org/10.1093/femsre/fux007 (2017).
5. Doern, C. D. When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing. Journal of Clinical Microbiology 52, 4124, https://doi.org/10.1128/JCM.01121-14 (2014).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献